ADAMTS9 is a novel cancer regulator that has been reported to be involved in a variety of cancers, such as gastric cancer [32], liver cancer [33], breast cancer [34], prostate cancer [35], and bladder cancer [36]. Here, ADAMTS9 is linked to prostate carcinoma.